1-5 of 5
germinal center b-cell-like diffuse large b-cell lymphoma
Close
Sort by
Journal Articles

The BET Inhibitor GS-626510 Converges with Idelalisib through the Inhibition of Tumor-Macrophage Crosstalk and Cytokine Production in Diffuse Large B-Cell Lymphoma

Juan G Valero, PhD, Aranzazu Chamorro-Jorganes, PhD, Katie Walker, PhD, Martina Guerrero-Hernandez, MSc, Vanina Rodriguez, Clara Recasens-Zorzo, MSc, Anna Esteve-Arenys, MSc, Eriong Lee-Verges, MSc, Alba Matas-Cespedes, PhD, Neus Serrat, PhD, Dolors Colomer, PhD, Armando Lopez-Guillermo, Stacey Tannheimer, PhD, Patricia Pérez-Galán, PhD, Gael Roue, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4108.
https://doi.org/10.1182/blood.V130.Suppl_1.4108.4108
Published: 2017
Journal Articles

Mutation Spectrum of Transformed Nodular Lymphocyte Predominant Hodgkin Lymphoma and Comparison with De Novo Diffuse Large B-Cell Lymphoma

Joo Y. Song, MD, Caoimhe Egan, Qiang Gong, PhD, Girish Venkataraman, MD MBBS, Alex F. Herrera, MD, Rebecca Ottesen, Joyce Niland, PhD, Dennis D. Weisenburger, MD, Elaine S. Jaffe, MD, Wing C Chan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1463.
https://doi.org/10.1182/blood.V130.Suppl_1.1463.1463
Published: 2017
Journal Articles

Increased Expression of EZH2 Is Associated with Inferior Survival in Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Briana Gibson, MD, Rahul Matnani, MBBS, PhD, Zheng Ping, MD, Balabhadrapatruni VSK Chakravarthi, Yang Yang, MD PhD, Sooryanarayana Varambally, PhD, Denise Peker, MD
Journal: Blood
Blood (2016) 128 (22): 4216.
https://doi.org/10.1182/blood.V128.22.4216.4216
Published: 2016
Journal Articles

Clinical Outcome and Survival of EBV-Positive Diffuse Large B-Cell Lymphoma.

Brady Beltran, MD, Pilar Quinones, MD, Domingo Morales, MD, Alex Capellino, MD, Roberto Miranda, MD, Carlos E. Bueso-Ramos, MD, Eduardo M. Sotomayor, MD, Jorge Castillo, MD
Journal: Blood
Blood (2009) 114 (22): 5005.
https://doi.org/10.1182/blood.V114.22.5005.5005
Published: 2009
Journal Articles

Effect of Adding Rituximab (R) to Induction Treatment and High Dose Chemotherapy (HDC) Prior to Autologous Stem Cell Transplantation (ASCT) as First Line Therapy in Stage III-IV Diffuse Large B-Cell Lymphoma (B-DLCL) at Poor Prognosis.

Umberto Vitolo, Giuseppe Rossi, Maria Giuseppina Cabras, Anna Marina Liberati, Annalisa Chiappella, Alessandro Levis, Enzo Pavone, Emanuele Angelucci, Barbara Botto, Manuela Ceccarelli, Roberto Freilone, Gianluca Gaidano, Domenico Novero, Lorella Orsucci, Isabella Palumbo, Enrico Pogliani, Delia Rota Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Eugenio Gallo
Journal: Blood
Blood (2005) 106 (11): 676.
https://doi.org/10.1182/blood.V106.11.676.676
Published: 2005